Back to Browse Journals » Clinical Epidemiology » Volume 5 » Issue 1

Monitoring human papillomavirus prevalence in urine samples: a review

Authors Enerly E, Olofsson C, Nygård M

Published Date March 2013 Volume 2013:5(1) Pages 67—79

DOI http://dx.doi.org/10.2147/CLEP.S39799

Received 31 October 2012, Accepted 28 December 2012, Published 12 March 2013

Espen Enerly, Cecilia Olofsson, Mari Nygård

Department of Research, Cancer Registry of Norway, Oslo, Norway

Abstract: Human papillomavirus (HPV) is the main cause of cervical cancer, and many countries now offer vaccination against HPV to girls by way of government-funded national immunization programs. Monitoring HPV prevalence in adolescents could offer a near-term biological measure of vaccine impact, and urine sampling may be an attractive large-scale method that could be used for this purpose. Our objective was to provide an overview of the literature on HPV DNA detection in urine samples, with an emphasis on adolescents. We searched the PubMed database using the terms “HPV” and “urine” and identified 21 female and 14 male study populations in which HPV prevalence in urine samples was reported, four of which included only asymptomatic female adolescents. We provide herein an overview of the recruitment setting, age, urine sampling procedure, lesion type, HPV assay, and HPV prevalence in urine samples and other urogenital samples for the studies included in this review. In female study populations, concordance for any HPV type and type-specific concordance in paired urine and cervical samples are provided in addition to sensitivity and specificity. We concluded that few studies on HPV prevalence in urine samples have been performed in asymptomatic female adolescent populations but that urine samples may be a useful alternative to cervical samples to monitor changes in HPV prevalence in females in the post-HPV vaccination era. However, care should be taken when extrapolating HPV findings from urine samples to the cervix. In males, urine samples do not seem to be optimal for monitoring HPV prevalence due to a low human genomic DNA content and HPV DNA detection rate compared to other urogenital sites. In each situation the costs and benefits of HPV DNA detection in urine compared to alternative monitoring options should be carefully considered.

Keywords: cervical cancer, HPV, surveillance, vaccination, virology, cervix

Corrigendum for this paper has been published

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Monitoring human papillomavirus prevalence in urine samples: a review [Corrigendum]

Enerly E, Olofsson C, Nygård M

Clinical Epidemiology 2013, 5:371-372

Published Date: 18 September 2013

Readers of this article also read:

Knowledge, attitude, and practices of infertility among Saudi couples

Abolfotouh MA, Alabdrabalnabi AA, Albacker RB, Al-Jughaiman UA, Hassan SN

International Journal of General Medicine 2013, 6:563-573

Published Date: 10 July 2013

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis

Johnston S, Brenu EW, Staines D, Marshall-Gradisnik S

Clinical Epidemiology 2013, 5:105-110

Published Date: 26 March 2013

Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography Screening

Langagergaard V, Garne JP, Vejborg I, Schwartz W, Bak M, Lernevall A, Mogensen NB, Larsson H, Andersen B, Mikkelsen EM

Clinical Epidemiology 2013, 5:81-88

Published Date: 14 March 2013

Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study

Fouad A, Sabry D, Ahmed R, Kamal M, Abd Allah S, Marzouk S, Amin M, Abd Al Aziz R, El Badri A, Khattab H, Helmy D

International Journal of General Medicine 2013, 6:127-134

Published Date: 12 March 2013

Evaluation of an algorithm ascertaining cases of osteonecrosis of the jaw in the Swedish National Patient Register

Bergdahl J, Jarnbring F, Ehrenstein V, Gammelager H, Granath F, Kieler H, Svensson M, Tell GS, Trolle Lagerros Y

Clinical Epidemiology 2013, 5:1-7

Published Date: 4 January 2013

Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory

Orem J, Sandin S, Weibull CE, Odida M, Wabinga H, Mbidde E, Wabwire-Mangen F, Meijer CJ, Middeldorp JM, Weiderpass E

Clinical Epidemiology 2012, 4:339-347

Published Date: 14 December 2012